Last 12 months
Inside the activity.
2 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2023 Filed Apr 5, 2023 17:27 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 560 | $33.48 | $18,748.80 |
DisclosureSEC source: 0001214659-23-004964 · marketforms-61174.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,020.32 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2022. F2 · balance_after: Represents 12,018.320 vested restricted stock units and 8,002 shares of Common Stock. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:26 UTC |
ZURAITIS MARITADirector · President & CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 866 | $0.00 Strike: $28.88 | $0.00 |
DisclosureSEC source: 0001214659-23-004902 · marketforms-61173.xml · derivative · entry 3 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 866 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:26 UTC |
ZURAITIS MARITADirector · President & CEO
|
Tax withholdingCommon Stock | 752 | $33.26 | $25,007.76 |
DisclosureSEC source: 0001214659-23-004902 · marketforms-61173.xml · nonDerivative · entry 2 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,886.941 F2 · shares: Disposition of pre-owned shares to satisfy exercise pursuant to the 2010 Comprehensive Executive Compensation Plan as amended and restated. F3 · balance_after: Represents 225,071.941 vested restricted stock units and 83,815 shares of Common Stock. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:26 UTC |
ZURAITIS MARITADirector · President & CEO
|
Exercise / conversionCommon Stock | 866 | $28.88 | $25,010.08 |
DisclosureSEC source: 0001214659-23-004902 · marketforms-61173.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,638.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 225,071.941 vested restricted stock units and 84,567 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:55 UTC |
Desrochers Mark RSenior Vice President
|
GrantCommon Stock | 2,495.857 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003745 · marketforms-60767.xml · nonDerivative · entry 2 Desrochers Mark R · CIK 0001479392 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,268.994 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 5,098.994 vested restricted stock units and 11,170 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:55 UTC |
Desrochers Mark RSenior Vice President
|
GrantCommon Stock | 3,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003745 · marketforms-60767.xml · nonDerivative · entry 1 Desrochers Mark R · CIK 0001479392 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,773.137 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 2,603.137 vested restricted stock units and 11,170 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:54 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
GrantCommon Stock | 1,783.319 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003743 · marketforms-60768.xml · nonDerivative · entry 2 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,329.407 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 22,106.407 vested restricted stock units and 2,223 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:54 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
GrantCommon Stock | 1,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003743 · marketforms-60768.xml · nonDerivative · entry 1 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,546.088 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 20,323.088 vested restricted stock units and 2,223 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:55 UTC |
Carley Donald MGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 13,104 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001214659-23-003744 · marketforms-60747.xml · derivative · entry 3 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,104 shares Expires 2033-03-08 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:55 UTC |
Carley Donald MGeneral Counsel
|
GrantCommon Stock | 4,991.706 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003744 · marketforms-60747.xml · nonDerivative · entry 2 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,920.474 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 15,522.474 vested restricted stock units and 14,398 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:55 UTC |
Carley Donald MGeneral Counsel
|
GrantCommon Stock | 2,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003744 · marketforms-60747.xml · nonDerivative · entry 1 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,928.768 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 10,530.768 vested restricted stock units and 14,398 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:53 UTC |
CONKLIN BRET AEVP & CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,964 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001214659-23-003742 · marketforms-60769.xml · derivative · entry 4 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,964 shares Expires 2033-03-08 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:53 UTC |
CONKLIN BRET AEVP & CFO
|
GrantCommon Stock | 7,843.038 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003742 · marketforms-60769.xml · nonDerivative · entry 2 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,874.955 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 44,384.641 vested share-based restricted stock units, 10,594.474 deferred cash restricted stock units and 12,895.840 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:53 UTC |
CONKLIN BRET AEVP & CFO
|
GrantCommon Stock | 3,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003742 · marketforms-60769.xml · nonDerivative · entry 1 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,031.917 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 36,541.603 vested share-based restricted stock units, 10,594.474 deferred cash restricted stock units and 12,895.840 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:51 UTC |
Fulks Stephanie ASenior Vice President
|
GrantCommon Stock | 1,425.763 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003741 · marketforms-60771.xml · nonDerivative · entry 2 Fulks Stephanie A · CIK 0001858286 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,376.654 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 2,833.654 vested restricted stock units and 9,543 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:51 UTC |
Fulks Stephanie ASenior Vice President
|
GrantCommon Stock | 2,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003741 · marketforms-60771.xml · nonDerivative · entry 1 Fulks Stephanie A · CIK 0001858286 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,950.891 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 1,407.891 vested restricted stock units and 9,543 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:51 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,964 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001214659-23-003740 · marketforms-60770.xml · derivative · entry 3 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,964 shares Expires 2033-03-08 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:51 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 7,843.038 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003740 · marketforms-60770.xml · nonDerivative · entry 2 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,150.832 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 65,087.832 vested restricted stock units and 63 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:51 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 3,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003740 · marketforms-60770.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,307.794 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 57,244.794 vested restricted stock units and 63 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:48 UTC |
Weckenbrock MichaelSenior Vice President
|
GrantCommon Stock | 1,070.388 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003739 · marketforms-60772.xml · nonDerivative · entry 2 Weckenbrock Michael · CIK 0001809094 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,866.449 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 2,890.449 vested restricted stock units and 4,976 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:48 UTC |
Weckenbrock MichaelSenior Vice President
|
GrantCommon Stock | 3,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003739 · marketforms-60772.xml · nonDerivative · entry 1 Weckenbrock Michael · CIK 0001809094 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,796.061 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 1,820.061 vested restricted stock units and 4,976 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:48 UTC |
Thayer JenniferChief Human Resources Officer
|
GrantCommon Stock | 1,070.388 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003738 · marketforms-60773.xml · nonDerivative · entry 2 Thayer Jennifer · CIK 0001808073 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,611.778 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 2,469.778 vested restricted stock units and 2,142 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:48 UTC |
Thayer JenniferChief Human Resources Officer
|
GrantCommon Stock | 2,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003738 · marketforms-60773.xml · nonDerivative · entry 1 Thayer Jennifer · CIK 0001808073 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,541.39 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 1,399.390 vested restricted stock units and 2,142 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:45 UTC |
ZURAITIS MARITADirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 134,432 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001214659-23-003737 · marketforms-60774.xml · derivative · entry 3 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 134,432 shares Expires 2033-03-08 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:45 UTC |
ZURAITIS MARITADirector · President & CEO
|
GrantCommon Stock | 31,368.986 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003737 · marketforms-60774.xml · nonDerivative · entry 2 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,682.385 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 236,574.385 vested restricted stock units and 76,108 shares of Common Stock. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 19:45 UTC |
ZURAITIS MARITADirector · President & CEO
|
GrantCommon Stock | 21,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-003737 · marketforms-60774.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,313.399 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 8, 2024. F2 · balance_after: Represents 205,205.399 vested restricted stock units and 76,108 shares of Common Stock. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 15:41 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,478 | $33.99 | $118,217.22 |
DisclosureSEC source: 0001214659-23-001373 · marketforms-58432.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,353.062 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.90 to $34.16. F3 · balance_after: Represents 54,290.062 vested restricted stock units and 63 shares of Common Stock. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 14:51 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 560 | $37.43 | $20,960.80 |
DisclosureSEC source: 0001214659-23-000238 · marketforms-58107.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,463.016 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2022. F2 · balance_after: Represents 11,901.016 vested restricted stock units and 8,562 shares of Common Stock. Read SEC document |
| December 27, 2022 Filed Dec 28, 2022 17:21 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $37.94 | $132,790.00 |
DisclosureSEC source: 0001214659-22-015392 · marketforms-57996.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,370.123 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2022. F2 · balance_after: Represents 53,829.123 vested restricted stock units and 3,541 shares of Common Stock. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 20:46 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $37.66 | $131,798.10 |
DisclosureSEC source: 0001214659-22-014308 · marketforms-57685.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,870.123 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.51 to $37.83. F3 · balance_after: Represents 53,829.123 vested restricted stock units and 7,041 shares of Common Stock. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 20:33 UTC |
BRADLEY THOMAS ADirector
|
PurchaseCommon Stock | 2,500 | $38.32 | $95,800.00 |
DisclosureSEC source: 0001214659-22-013618 · marketforms-57524.xml · nonDerivative · entry 1 BRADLEY THOMAS A · CIK 0001198917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,795.557 F1 · balance_after: Represents 2,795.557 vested restricted stock units and 10,000 shares of Common Stock. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 12:48 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $37.91 | $132,667.85 |
DisclosureSEC source: 0001214659-22-012637 · marketforms-57363.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,370.123 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.55 to $38.23. F3 · balance_after: Represents 53,829.123 vested restricted stock units and 10,541 shares of Common Stock. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 13:15 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $36.04 | $126,126.35 |
DisclosureSEC source: 0001214659-22-011610 · marketforms-57196.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,386.4 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.48 to $36.24. F3 · balance_after: Represents 53,345.400 vested restricted stock units and 14,041 shares of Common Stock. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:24 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 560 | $35.21 | $19,717.60 |
DisclosureSEC source: 0001214659-22-010906 · marketforms-57064.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,815.935 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2022. F2 · balance_after: Represents 11,693.935 vested restricted stock units and 9,122 shares of Common Stock. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 13:19 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $36.12 | $126,416.85 |
DisclosureSEC source: 0001214659-22-010750 · marketforms-57017.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,886.4 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.49. F3 · balance_after: Represents 53,345.400 vested restricted stock units and 17,541 shares of Common Stock. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 17:12 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $34.43 | $120,493.80 |
DisclosureSEC source: 0001214659-22-009481 · marketforms-56785.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,386.4 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.18 to $34.53. F3 · balance_after: Represents 53,345.400 vested restricted stock units and 21,041 shares of Common Stock. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 18:50 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 525 | $38.07 | $19,986.75 |
DisclosureSEC source: 0001214659-22-007893 · marketforms-56429.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,279.352 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021. F2 · balance_after: Represents 14,477.352 vested restricted stock units and 6,802 shares of Common Stock. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:28 UTC |
Casady Mark SDirector
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007504 · marketforms-56372.xml · nonDerivative · entry 1 Casady Mark S · CIK 0001405275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,308.207 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:33 UTC |
Domenech Daniel ADirector
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007510 · marketforms-56373.xml · nonDerivative · entry 1 Domenech Daniel A · CIK 0001642977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,447.699 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 18,081.572 vested share-based restricted stock units and 7,366.127 deferred cash restricted stock units. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:33 UTC |
Sarsynski Elaine ADirector
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007509 · marketforms-56378.xml · nonDerivative · entry 1 Sarsynski Elaine A · CIK 0001552249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:32 UTC |
Reece Henry WadeDirector
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007508 · marketforms-56377.xml · nonDerivative · entry 1 Reece Henry Wade · CIK 0001675638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,571.06 F1 · security: The acquisition of Common Stock reported hereby is in the form of share-based restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 14,957.185 vested share-based restricted stock units and 7,613.875 deferred cash restricted stock units. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:31 UTC |
McClure Beverley J.Director
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007507 · marketforms-56376.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,910.301 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 11,583.301 vested restricted stock units and 7,327 shares of Common Stock. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:30 UTC |
Hines Perry G.Director
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007505 · marketforms-56374.xml · nonDerivative · entry 1 Hines Perry G. · CIK 0001741555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,703.076 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:30 UTC |
KONEN MARK EDirector
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007506 · marketforms-56375.xml · nonDerivative · entry 1 KONEN MARK E · CIK 0001280429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,308.207 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:28 UTC |
BRADLEY THOMAS ADirector
|
GrantCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-007503 · marketforms-56371.xml · nonDerivative · entry 1 BRADLEY THOMAS A · CIK 0001198917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 25, 2023. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 7,500 shares of Common Stock held directly. Read SEC document |
| May 11, 2022 Filed May 12, 2022 17:00 UTC |
BRADLEY THOMAS ADirector
|
PurchaseCommon Stock | 5,000 | $37.96 | $189,800.00 |
DisclosureSEC source: 0001214659-22-006655 · marketforms-56172.xml · nonDerivative · entry 1 BRADLEY THOMAS A · CIK 0001198917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 17:52 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 525 | $42.25 | $22,181.25 |
DisclosureSEC source: 0001214659-22-004837 · marketforms-55968.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,910.301 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021. F2 · balance_after: Represents 11,583.301 vested restricted stock units and 7,327 shares of Common Stock. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:45 UTC |
Weckenbrock MichaelSenior Vice President
|
GrantCommon Stock | 1,199.973 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-003887 · marketforms-55774.xml · nonDerivative · entry 2 Weckenbrock Michael · CIK 0001809094 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,041.442 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 2,402.442 vested restricted stock units and 1,639 shares of Common Stock. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:45 UTC |
Weckenbrock MichaelSenior Vice President
|
GrantCommon Stock | 2,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-003887 · marketforms-55774.xml · nonDerivative · entry 1 Weckenbrock Michael · CIK 0001809094 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,841.469 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 9, 2023. F2 · balance_after: Represents 1,202.469 vested restricted stock units and 1,639 shares of Common Stock. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:45 UTC |
ZURAITIS MARITADirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 105,796 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0001214659-22-003888 · marketforms-55775.xml · derivative · entry 3 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 105,796 shares Expires 2032-03-09 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 9, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.